| Literature DB >> 31384269 |
Alba Maria Ropero Alvarez1, Hannah Jane Kurtis1, Lauren Vulanovic1, Hayatee Hasan2, Cuauhtémoc Ruiz1, Elizabeth Thrush1.
Abstract
This report covers the background and evolution of Vaccination Week in the Americas (VWA), an initiative that started as a coordinated response to a 2002 measles outbreak in Colombia and Venezuela, and evolved into the model for other regions and World Immunization Week (WIW). VWA focuses on the work of national immunization programs, with special efforts to reach the unreached. This paper offers examples of how countries have leveraged VWA to implement a diverse array of vaccination activities, strengthening overall health services by integrating with other preventive health interventions, and bolstering "Pan-Americanism" and health diplomacy. The opportunities offered by this global initiative were clearly demonstrated in April 2016 when the successful global switch from the trivalent oral polio vaccine to the bivalent vaccine was synchronized with WIW. Going forward, VWA and WIW can help close the gaps in access to immunization and other health services, contributing to achieve universal health coverage.Entities:
Keywords: Americas; Immunization programs; global health; health diplomacy; mass vaccination
Year: 2017 PMID: 31384269 PMCID: PMC6645237 DOI: 10.26633/RPSP.2017.150
Source DB: PubMed Journal: Rev Panam Salud Publica ISSN: 1020-4989
FIGURE 1.Estimated number of people vaccinated, by age group, as part of VaccinationWeek in the Americas (VWA), 2003–2017
FIGURE 2Timeline of Vaccination Week in the Americas (VWA) and other sister vaccination week initiatives, 2002–2017
Estimated cumulative number of vaccines administered by antigen as part of Vaccination Week in the Americas (VWA), 2006–2017
Vaccine | Estimated number of doses |
|---|---|
Influenza | 296 884 930 |
Polio | 109 163 189 |
Measles | 69 130 983 |
Diphtheria–Pertussis–Tetanus | 31 413 900 |
Hepatitis B | 14 857 484 |
Yellow fever | 14 177 613 |
Pneumococcal | 6 383 336 |
Pentavalenta | 5 295 722 |
Rotavirus | 3 464 394 |
Bacillus Calmette-Guérin | 1 965 438 |
Varicella | 1 869 637 |
Human Papilomavirus | 1 195 970 |
Haemophilus influenza type b | 491 322 |
Other (not specified) | 3 218 306 |
Estimates based on final country reports to PAHO/WHO for Vaccination Week in the Americas, 2006–2017.